Obermatt

Flags

Financial distress

Bionano Genomics

NAQ:BNGO · US09075F4046
Life Sciences Tools & ServicesSmall

360° View

17
Price/Sales97
Price/Earnings60
Price/Book85
Dividend Yield1
Revenue Growth90
Profit Growth34
Capital Growth31
TSR 52w9
Leverage44
Liquidity7
Refinancing99
Combined29
Analyst Opinions66
Pro Holdings7
Opinion Changes50
Market Pulse9

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2003
Employees136
ISINUS09075F4046
Last UpdateApr 2, 2026
Index & Theme
Biomedical EngineeringHealth DiagnosticsGeneticsHematologyMachine LearningSoftware DevelopmentGenetic DisorderBiotechnologyMedical

Description

Bionano Genomics, Inc. provides genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The company offers a platform-agnostic software solution, which integrates next-…

Analysis

Bionano Genomics's 360° View rank of 17 places it among the weakest overall — better than 17% of its true peers.

It's lagging on growth (17) and looks cheap versus peers (93). On safety it is carrying more balance-sheet risk (29), and the market shows skeptical sentiment (9). Taken together, its Combined rank of 29 reads as below its peer average.

360° rank · history

1007550250
17
2023202420252026

All-time high

84

Jan 2024

All-time low

10

Jan 2025

Average rank

51

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
97
93
86
1
Price/Earnings
60
18
18
18
Price/Book
85
14
91
87
Dividend Yield
1
1
1
1
Value (overall)
93
47
83
37

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Bionano Genomics with its peers
OmniAb
NMQ:OABI
61
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Seer
NSQ:SEER
43
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
AbCellera Biologics
NSQ:ABCL
19
CountryCanada
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Quanterix
NMQ:QTRX
43
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
10x Genomics
NSQ:TXG
38
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →
Alpha Teknova
NMQ:TKNO
32
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →